2018 Maryland Code
Insurance
Title 15 - Health Insurance
Subtitle 16 - Pharmacy Benefits Managers
Part III - Pharmacy and Therapeutics Committees
§ 15-1617. Required policies, procedures, and processes.

Universal Citation: MD Ins Code § 15-1617 (2018)
    A pharmacy benefits manager shall ensure that its pharmacy and therapeutics committee has:
  • (1) policies and procedures, including disclosure requirements, to address potential conflicts of interest that members of the pharmacy and therapeutics committee may have with developers or manufacturers of prescription drugs;

  • (2) a process to evaluate medical and scientific evidence concerning the safety and effectiveness of prescription drugs, including available comparative information on clinically similar prescription drugs, when deciding what prescription drugs to recommend to include on a formulary;

  • (3) a process to evaluate medical and scientific evidence concerning the safety and effectiveness of prescription drugs when recommending utilization review requirements, dose restrictions, and step therapy requirements; and

  • (4) a process to enable the pharmacy and therapeutics committee to consider the need to recommend a formulary change to a purchaser in a timely manner but at least annually.

Disclaimer: These codes may not be the most recent version. Maryland may have more current or accurate information. We make no warranties or guarantees about the accuracy, completeness, or adequacy of the information contained on this site or the information linked to on the state site. Please check official sources.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.